Categories AlphaGraphs, Earnings, Technology
Earnings: Lam Research Q4 profit falls but beats estimates
Lam Research (NASDAQ: LRCX) reported lower revenues and earnings for the fourth quarter of 2019. Earnings exceeded the estimates, while revenues matched the forecast.
The Fremont, California-based semiconductor technology company reported revenues of $2.36 billion for the fourth quarter, in line with analysts’ forecast. It is lower by 24% than the revenue reported a year earlier.
Adjusted earnings dropped to $3.62 per share during the three-month period from $3.70 per share in the fourth quarter of 2018. Reported profit fell sharply to $541.8 million or $3.51 per share from $1.02 billion or $5.82 per share last year. The bottom line, however, topped the Street view.
“Lam’s June quarter results reflect our strong track record of execution. We are making solid progress on our innovation roadmap, and with multiple technology inflections ahead of us, Lam is in an excellent position to win,” said CEO Timothy Archer.
For the first quarter, the management expects revenues of $2.15 billion, plus or minus $150 million. The forecast for adjusted earnings is $3.00 per share, plus or minus 20 cents. Unadjusted earnings are expected to be $2.91 per share in the September quarter, plus or minus 20 cents. The company is looking for gross margins of about 45%.
The long-term outlook for the semiconductor industry is positive as it made a significant recovery in 2019 after being battered by multiple headwinds including the US-China trade war softening global economy and the cryptocurrency crash.
Last week, Lam Research shares surged to an all-time high. The stock has gained 53% so far this year and 13% in the past twelve months. It closed Wednesday’s regular session lower.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was